Ondansetron hcl injection
Products billed under this code include Ondansetron HCl.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Ondansetron HCl.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Ondansetron HCl | Henry Schein Inc. | 00404-9930-02 | 4 | $0.336 |
| Ondansetron HCl | Pfizer Inc | 00409-0009-25 | 100 | $8.40 |
| Ondansetron HCl | Pfizer Inc | 00409-2271-25 | 100 | $8.40 |
| Ondansetron HCl | Pfizer Inc | 00409-4755-03 | 100 | $8.40 |
| Ondansetron HCl | Pfizer Inc | 00409-4759-01 | 40 | $3.36 |
| Ondansetron HCl | Hikma Pharmaceuticals USA Inc. | 00641-6078-25 | 100 | $8.40 |
| Ondansetron HCl | Hikma Pharmaceuticals USA Inc. | 00641-6079-01 | 40 | $3.36 |
| Ondansetron HCl | Hikma Pharmaceuticals USA Inc. | 00641-6080-25 | 100 | $8.40 |
| Ondansetron HCl | Hikma Pharmaceuticals USA Inc. | 00641-6286-01 | 40 | $3.36 |
| Ondansetron HCl | Accord Healthcare Inc | 16729-0298-05 | 40 | $3.36 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Ondansetron HCl | Heritage Pharmaceuticals Inc. | 23155-0547-42 | 100 | $8.40 |
| Ondansetron HCl | Heritage Pharmaceuticals Inc. | 23155-0548-42 | 100 | $8.40 |
| Ondansetron HCl | Heritage Pharmaceuticals Inc. | 23155-0549-31 | 40 | $3.36 |
| Ondansetron HCl | Heritage Pharmaceuticals Inc. | 23155-0550-31 | 40 | $3.36 |
| Ondansetron HCl | Sagent Pharmaceuticals | 25021-0777-02 | 100 | $8.40 |
| Ondansetron HCl | Baxter Healthcare Corporation | 36000-0012-25 | 100 | $8.40 |
| Ondansetron HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1245-01 | 4 | $0.336 |
| Ondansetron HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1245-03 | 100 | $8.40 |
| Ondansetron HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1377-01 | 40 | $3.36 |
| Ondansetron HCl | Apotex Corp | 60505-6130-05 | 100 | $8.40 |
| Ondansetron HCl | FreseniUS Kabi USA, LLC | 63323-0373-02 | 100 | $8.40 |
| Ondansetron HCl | FreseniUS Kabi USA, LLC | 63323-0374-20 | 40 | $3.36 |
| Ondansetron HCl | FreseniUS Kabi USA, LLC | 65219-0323-02 | 100 | $8.40 |
| Ondansetron HCl | Athenex Pharmaceutical Division, LLC | 70860-0776-02 | 100 | $8.40 |
| Ondansetron HCl | Athenex Pharmaceutical Division, LLC | 70860-0777-21 | 400 | $33.60 |
| Ondansetron HCl | Fosun Pharma USA Inc. | 72266-0123-25 | 100 | $8.40 |
| Ondansetron HCl | Fosun Pharma USA Inc. | 72266-0124-01 | 40 | $3.36 |
| Ondansetron HCl | Civica, Inc. | 72572-0520-25 | 100 | $8.40 |
| Ondansetron HCl | FreseniUS Kabi USA, LLC | 76045-0216-20 | 96 | $8.064 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.084 | −$0.004 | 1 MG | Ondansetron hcl injection | v1, posted September 17, 2026 |
| 3Q26 | $0.088 | $0.00 | 1 MG | Ondansetron hcl injection | v1, posted September 15, 2026 |
| 2Q26 | $0.088 | −$0.005 | 1 MG | Ondansetron hcl injection | v1, posted September 15, 2026 |
| 1Q26 | $0.093 | +$0.002 | 1 MG | Ondansetron hcl injection | v1, posted September 15, 2026 |
| 4Q25 | $0.091 | −$0.001 | 1 MG | Ondansetron hcl injection | v1, posted September 8, 2026 |
| 3Q25 | $0.092 | +$0.006 | 1 MG | Ondansetron hcl injection | v1, posted March 10, 2026 |
| 2Q25 | $0.086 | −$0.004 | 1 MG | Ondansetron hcl injection | v1, posted March 10, 2026 |
| 1Q25 | $0.09 | +$0.001 | 1 MG | Ondansetron hcl injection | v1, posted December 19, 2025 |
| 4Q24 | $0.089 | −$0.003 | 1 MG | Ondansetron hcl injection | v1, posted June 11, 2025 |
| 3Q24 | $0.092 | −$0.003 | 1 MG | Ondansetron hcl injection | v1, posted June 11, 2025 |
| 2Q24 | $0.095 | −$0.005 | 1 MG | Ondansetron hcl injection | v1, posted March 11, 2025 |
| 1Q24 | $0.10 | +$0.01 | 1 MG | Ondansetron hcl injection | v1, posted December 19, 2024 |
| 4Q23 | $0.09 | −$0.021 | 1 MG | Ondansetron hcl injection | v1, posted October 10, 2024 |
| 3Q23 | $0.111 | +$0.018 | 1 MG | Ondansetron hcl injection | v1, posted June 5, 2024 |
| 2Q23 | $0.093 | $0.00 | 1 MG | Ondansetron hcl injection | v1, posted February 23, 2024 |
| 1Q23 | $0.093 | +$0.007 | 1 MG | Ondansetron hcl injection | v1, posted December 6, 2023 |
| 4Q22 | $0.086 | $0.00 | 1 MG | Ondansetron hcl injection | v1, posted June 22, 2023 |
| 3Q22 | $0.086 | $0.00 | 1 MG | Ondansetron hcl injection | v1, posted June 9, 2023 |
| 2Q22 | $0.086 | +$0.002 | 1 MG | Ondansetron hcl injection | v1, posted December 14, 2022 |
| 1Q22 | $0.084 | −$0.003 | 1 MG | Ondansetron hcl injection | v1, posted June 8, 2022 |
| 4Q21 | $0.087 | −$0.003 | 1 MG | Ondansetron hcl injection | v1, posted June 2, 2022 |
| 3Q21 | $0.09 | −$0.005 | 1 MG | Ondansetron hcl injection | v1, posted June 2, 2022 |
| 2Q21 | $0.095 | +$0.002 | 1 MG | Ondansetron hcl injection | v1, posted March 1, 2022 |
| 1Q21 | $0.093 | – | 1 MG | Ondansetron hcl injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.